ISSN: 1744-6872

Journal Home

Journal Guideline

Pharmacogenetics and Genomics Q3 Unclaimed

Lippincott Williams and Wilkins Ltd. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Pharmacogenetics and Genomics is a journal indexed in SJR in Molecular Biology and Genetics with an H index of 139. It has an SJR impact factor of 0,774 and it has a best quartile of Q3. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Genetics (Q3) Genetics (clinical) (Q3) Genetics (clinical) (Q3) Molecular Biology (Q3) Molecular Medicine (Q3)

Price

- €

Gold OA

-

Green OA

- €

Non OA

Metrics

0,774

SJR Impact factor

139

H Index

30

Total Docs (Last Year)

176

Total Docs (3 years)

911

Total Refs

448

Total Cites (3 years)

162

Citable Docs (3 years)

2,85

Cites/Doc (2 years)

30,37

Ref/Doc

Aims and Scope

Other journals with similar parameters

Molecular Membrane Biology Q3
American Journal of Stem Cells Q3
Clinical and Molecular Allergy Q3
Genetics and Molecular Biology Q3
Stem Cell Investigation Q3

Best articles

A comparison of DMET Plus microarray and genome-wide technologies by assessing population substructure

A human leukocyte antigen locus haplotype confers risk for allopurinol-related adverse effects in Caucasian patients with gout

A novel ABCC6 haplotype is associated with azathioprine drug response in myasthenia gravis

A pharmacogene database enhanced by the 1000 Genomes Project

A possible association of the norepinephrine transporter gene in the development of heroin dependence in Han Chinese

A systematic analysis and comparison of warfarin initiation strategies

Aberrant CYP2D6 metabolizer phenotypes do not show increased frequency in patients undergoing ECT after antidepressant therapy

ADH4 intronic variations are associated with alcohol dependence

Angiotensin-converting enzyme activity in Cavalier King Charles Spaniels with an ACE gene polymorphism and myxomatous mitral valve disease

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients

Association between TAAR6 polymorphisms and airway responsiveness to inhaled corticosteroids in asthmatic patients

Association of (pro)renin receptor gene polymorphism with blood pressure in Caucasian men

SHOW MORE ARTICLES

Association of multidrug resistance-associated protein 2 single nucleotide polymorphism rs12762549 with the basal plasma levels of phase II metabolites of isoflavonoids in healthy Japanese individuals

Bioavailability of testosterone enanthate dependent on genetic variation in the phosphodiesterase 7B but not on the uridine 5'-diphospho-glucuronosyltransferase (UGT2B17) gene.

Cerivastatin, genetic variants, and the risk of rhabdomyolysis

Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient

Codeine and morphine pathway

Comment on Xie et al.

Comprehensive evaluation of the neuropeptide-Y gene variants in the risk of obesity

CYP1A21*F contains the -163C >A substitution and is highly inducible

CYP1A21*F contains the -163C>A substitution and is highly inducible

CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers

CYP2C9 promoter region single-nucleotide polymorphisms linked to the R150H polymorphism are functional suggesting their role in CYP2C9*8-mediated effects

CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population

Comments

No comments ... Be the first to comment!

Publication speed

Review quality

Edition and editorial team

Paper Link

Attach one of your papers. We need to confirm that you have had a relation with this journal in order to review its service.